Download the Whitepaper
Beyond the Buzzword
A 3D Framework for Strategic Co-Creation in Pharma
Co-creation is no longer a nice-to-have. It’s an essential capability for delivering meaningful, measurable value to patients, healthcare professionals, and systems. Yet in practice, co-creation often remains fragmented — reduced to isolated pilots or symbolic workshops.
This whitepaper introduces a 3D model that helps pharma leaders, cross-functional teams, and policy stakeholders evaluate and scale co-creation strategically.
What you’ll learn:
-
A clear definition of co-creation in the pharmaceutical context
-
A structured 3D model across three key dimensions:
→ Customer Experience
→ Organizational Maturity
→ Level of Application -
Real-world pharma examples mapped in the model
-
Strategic prompts, risk zones, and governance implications
-
Tools to support assessment, prioritization, and transformation
Who should read this:
-
Market access & medical affairs professionals
-
CX, PSP, and innovation teams
-
Policy and compliance stakeholders
-
Anyone working to make co-creation real — and scalable — in pharma
Get the whitepaper
Fill in the form to download your copy and take the next step toward embedding co-creation in strategy, structure, and everyday decisions.